OEC Orion S.A.
Miscellaneous Chemical Products · NYSE · SEC CIK 1609804 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY0.9%
TTM net income YoY-1.6%
TTM EPS YoY0.0%
Revenue 3-yr CAGR-0.8%
Net income 3-yr CAGR—
Margins
Gross margin18.5%
Operating margin4.0%
Net margin-1.8%
FCF margin2.4%
EBITDA margin11.6%
Returns
ROE-8.1%
ROA-1.6%
ROIC (approx.)2.7%
Asset turnover0.94x
Leverage & solvency
Liabilities / assets79.7%
Debt / equity2.48x
Current ratio1.06x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-5.13x
Accruals ratio-10.1%
Payout ratio—
Capex / revenue6.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $1.81B | $1.88B |
| Cost of revenue | $1.45B | $1.45B |
| Gross profit | $359.80M | $428.80M |
| R&D expense | $27.50M | $27.10M |
| SG&A expense | $230.70M | $237.80M |
| Operating income | $27.50M | $102.70M |
| Pretax income | -$34.30M | $53.90M |
| Income tax | $35.80M | $9.70M |
| Net income | -$70.10M | $44.20M |
| EBITDA | $159.40M | $228.00M |
| EPS (basic) | -1.24 | 0.76 |
| EPS (diluted) | -1.24 | 0.76 |
| Dividends declared per share | 0.08 | 0.08 |
| Weighted avg. shares (diluted) | 56.32M | 58.37M |
| Balance sheet | ||
| Cash & equivalents | $60.70M | $44.70M |
| Receivables | $213.60M | $211.90M |
| Inventory | $277.30M | $290.40M |
| Current assets | $643.80M | $613.30M |
| PP&E, net | $1.07B | $965.00M |
| Goodwill | $0 | $71.50M |
| Intangibles | $14.20M | $18.50M |
| Total assets | $1.91B | $1.86B |
| Current liabilities | $626.40M | $516.70M |
| Short-term debt | $305.00M | $258.80M |
| Long-term debt | $674.50M | $647.00M |
| Total debt | $979.50M | $905.80M |
| Total liabilities | $1.52B | $1.38B |
| Shareholders' equity | $384.60M | $474.90M |
| Net debt | $918.80M | $861.10M |
| Shares outstanding | 56.15M | 57.24M |
| Cash flow statement | ||
| Operating cash flow | $215.80M | $125.30M |
| Capital expenditure | $161.00M | $206.70M |
| Free cash flow | $54.80M | -$81.40M |
| Investing cash flow | -$161.00M | -$206.70M |
| Financing cash flow | -$41.20M | $89.30M |
| Depreciation & amortization | $131.90M | $125.30M |
| Stock-based compensation | $13.60M | $15.30M |
| Dividends paid | $4.70M | $4.80M |
| Share buybacks | $24.80M | $26.60M |
Free plan shows the latest 2 periods; Pro shows all 11 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.